abstract |
The present invention is novel to demonstrate the effect of protecting target cells from HIV infection in a manner that specifically binds to chemokine receptors, thereby affecting the binding of natural ligands or chemokines to target cell receptors such as CXCR4 and / or CCR5. One compound is provided. |